Roche Profit Falls on Strong Franc as New-Drug Sales Rise

Roche Holding AG, the world’s biggest maker of cancer drugs, said first-half profit fell 7 percent as the strength of the Swiss franc offset rising sales of new medicines.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.